VEGFA and retinal detachment: Conversely, administration of intravitreal anti-VEGF agents directly reduces VEGF levels in the ocular environment, resulting in a more rapid mechanism of action than LPC [26]. In our study, three infants developed retinal detachment between 12 and 18 weeks following their initial IVR treatment.